Origin

From a cross of a Bagg albino female and a DBA male by Strong in 1920. The CBA strain was selected for a low mammary tumour incidence. Transferred via The Jackson Laboratory to Haldane and Gruneberg in 1932. To Carter (CBA/Ca) in 1947. VAF/Plus breed stock to Charles River Laboratories UK from Glaxo in 1992.

MHC Haplotype

H-1a, H-2k, H-3

Ideal For:

Research applications include brain development, neurochemistry and behavioural studies

Strain Code:

N/A

  • Bred In:
  • UK

I need to…

Pre-identify my CBA mice.

Our Pre-ID™ services enable you to receive animal models that have been identified with the codes you provide us.